UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).

Anthony Barnett, HL Millar, JY Loze, GJ L'Italien, M van Baardewijk, M Knapp

Research output: Contribution to journalArticle

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).'. Together they form a unique fingerprint.

Medicine & Life Sciences